Value of colonoscopy for prediction of prognosis in patients with ulcerative colitis

World Journal of Gastroenterology

Volumn 14, Issue 14, 2008, Pages 2133-2138

  Ando, Takafumi ^a   Nishio, Yuji ^a,b   Watanabe, Osamu ^a   Takahashi, Hironao ^a   Maeda, Osamu ^a   Ishiguro, Kazuhiro ^a   Ishikawa, Daisuke ^a   Ohmiya, Naoki ^a   Niwa, Yasumasa ^a   Goto, Hidemi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Meitetsu Hospital   (Japan)

Author keywords

Colonoscopy; Prediction of outcome; Ulcerative colitis

Indexed keywords

CYCLOSPORIN; GLUCOCORTICOID; STEROID;

COLON RESECTION; COLONOSCOPY; DISEASE ACTIVITY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG MECHANISM; EDITORIAL; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LEUKAPHERESIS; LIVER TOXICITY; MEDICAL DECISION MAKING; NEPHROTOXICITY; PARESTHESIA; PNEUMOCYSTIS PNEUMONIA; PREDICTION; PROGNOSIS; RECURRENT DISEASE; REMISSION; SEIZURE; TREATMENT RESPONSE; TREMOR; ULCERATIVE COLITIS; CONFOCAL MICROSCOPY; ENDOSCOPY; GASTROENTEROLOGY; LEUKOCYTE; METABOLISM; METHODOLOGY; REVIEW; TIME; TREATMENT OUTCOME;

COLITIS, ULCERATIVE; COLONOSCOPY; CYCLOSPORINE; ENDOSCOPY; GASTROENTEROLOGY; HUMANS; LEUKOCYTES; MICROSCOPY, CONFOCAL; PROGNOSIS; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 49249088754     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.2133     Document Type: Editorial

References (66)

1. Ritchie JK, Powell-Tuck J, Lennard-Jones JE. Clinical outcome of the first ten years of ulcerative coIitis and proctitis. Lancet 1978; 1: 1140-1143
2. Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994; 107: 3-11
3. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut 1963; 4: 299-315
4. Selby W. The natural history of ulcerative colitis. Baillieres Clin Gastroenterol 1997; 11: 53-64
5. Hiwatashi N, Yao T, Watanabe H, Hosoda S, Kobayashi K, Saito T, Terano A, Shimoyama T, Muto T. Long-term follow-up study of ulcerative colitis in Japan. J Gastroenterol 1995; 30 Suppl 8: 13-16
6. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. III. complications. Gut 1964; 5: 1-22
7. Nash CL, Sutherland LR. Medical management of inflammatory bowel disease: old and new perspectives. Curr Opin Gastroenterol 2001; 17: 336-341
8. Katz JA. Management of inflammatory bowel disease in adults. J Dig Dis 2007; 8: 65-71
9. Hanauer SB, Present DH. The state of the art in the management of inflammatory bowel disease. Rev Gastroenterol Disord 2003; 3: 81-92
10. Travis S. Recent advances in immunomodulation in the treatment of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2003; 15: 215-218
11. Siveke JT, Folwaczny C. Medical approaches and future options in chronic active ulcerative colitis. Int J Colorectal Dis 2004; 19: 297-307
12. George J, Present DH, Pou R, Bodian C, Rubin PH. The long-term outcome of ulcerative colitis treated with 6-mercaptopurine. Am J Gastroenterol 1996; 91: 1711-1714
13. Matts SG. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 1961; 30: 393-407
14. Powell-Tuck J, Day DW, Buckell NA, Wadsworth J, Lennard-Jones JE. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci 1982; 27: 533-537
15. Riley SA, Mani V, Goodman MJ, Dutt S, Herd ME. Microscopic activity in ulcerative colitis: what does it mean? Gut 1991; 32: 174-178
16. Kudo S, Rubio CA, Teixeira CR, Kashida H, Kogure E. Pit pattern in colorectaI neoplasia: endoscopic magnifying view. Endoscopy 2001; 33: 367-373
17. Kato S, Fujii T, Koba I, Sano Y, Fu KI, Parra-Blanco A, Tajiri H, Yoshida S, Rembacken B. Assessment of colorectal lesions using magnifying colonoscopy and mucosal dye spraying: can significant lesions be distinguished? Endoscopy 2001; 33: 306-310
18. Kiesslich R, Fritsch J, Holtmann M, Koehler HH, Stolte M, Kanzler S, Nafe B, Jung M, Galle PR, Neurath MF. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003; 124: 880-888
19. Hurlstone DP, Cross SS, Adam I, Shorthouse AJ, Brown S, Sanders DS, Lobo AJ. Efficacy of high magnification chromoscopic colonoscopy for the diagnosis of neoplasia in flat and depressed lesions of the colorectum: a prospective analysis. Gut 2004; 53: 284-290
20. Hurlstone DP, Cross SS. Role of aberrant crypt foci detected using high-magnification-chromoscopic colonoscopy in human colorectaI carcinogenesis. J Gastroenterol Hepatol 2005; 20: 173-181
21. Poulsen SS, Christensen KC, Petri M, Jarnum S. Stereomicroscopic examination of stained rectal biopsies in ulcerative colitis and Crohn's disease. Scand J Gastroenterol 1980; 15: 535-544
22. Lichtiger S, Present DH. Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lancet 1990; 336: 16-19
23. Lichtiger S. Cyclosporine therapy in inflammatory bowel disease: open-label experience. Mt Sinai J Med 1990; 57: 315-319
24. Santos J, Baudet S, Casellas F, Guarner L, Vilaseca J, Malagelada JR. Efficacy of intravenous cyclosporine for steroid refractory attacks of ulcerative colitis. J Clin Gastroenterol 1995; 20: 285-289
25. Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterol 1999; 94: 1587-1592
26. Cohen RD. Intravenous cyclosporine in severe ulcerative colitis: ready to stand alone? Gastroenterology 2001; 120: 1541-1543
27. Stack WA, Long RG, Hawkey CJ. Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis. Aliment Pharmacol Ther 1998; 12: 973-978
28. Rowe FA, Walker JH, Karp LC, Vasihauskas EA, Plevy SE, Targan SR. Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis. Am J Gastroenterol 2000; 95: 2000-2008
29. McCormack G, O'Donoghue D, Baird A. In-vitro cyclosporin sensitivity of proliferating lymphocytes is predictive of in-vivo therapeutic response in ulcerative colitis. Aliment Pharmacol Ther 2001; 15: 665-668
30. Daniel F, Loriort MA, Seksik P, Cosnes J, Gornet JM, Lemann M, Fein F, Vernier-Massouille G, De Vos M, Boureille A, Treton X, Flourie B, Roblin X, Louis E, Zerbib F, Beaune P, Marteau P. Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis. Inflamm Bowel Dis 2007; 13: 19-23
31. Noguchi A, Watanabe K, Narumi S, Yamagami H, Fujiwara Y, Higuchi K, Oshitani N, Arakawa T. The production of interferon-gamma-inducible protein 10 by granulocytes and monocytes is associated with ulcerative colitis disease activity. J Gastroenterol 2007; 42: 947-956
32. Yamamoto T, Umegae S, Matsumoto K. Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis. World J Gastroenterol 2006; 12: 520-525
33. Weissmann G. Lysosomal mechanisms of tissue injury in arthritis. N Engl J Med 1972; 286: 141-147
34. Edwards SW, Hallett MB. Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol Today 1997; 18: 320-324
35. Kurtel H, Granger DN, Tso P, Grisham MB. Vulnerability of intestinal interstitial fluid to oxidant stress. Am J Physiol 1992; 263: G573-G578
36. Sakai T, Kusugami K, Nishimura H, Ando T, Yamaguchi T, Ohsuga M, Ina K, Enomoto A, Kimura Y, Yoshikai Y. Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. Gastroenterology 1998; 114: 1237-1243
37. Sawada K. Leukocytapheresis as an adjunct to conventional medication for inflammatory bowel disease. Dis Colon Rectum 2003; 46: S66-S77
38. Saniabadi AR, Hanai H, Takeuchi K, Umemura K, Nakashima M, Adachi T, Shima C, Bjarnason I, Lofberg R. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial 2003; 7: 48-59
39. Shirokaze J. Leukocytapheresis using a leukocyte removal filter. Ther Apher 2002; 6: 261-266
40. Sawada K, Ohnishi K, Kosaka T, Fukui S, Yamamura M, Amano K, Satomi M, Shimoyama T. Leukocytapheresis therapy with leukocyte removal filter for inflammatory bowel disease. J Gastroenterol 1995; 30 Suppl 8: 124-127
41. Shimoyama T, Sawada K, Hiwatashi N, Sawada T, Matsueda K, Munakata A, Asakura H, Tanaka T, Kasukawa R, Kimura K, Suzuki Y, Nagamachi Y, Muto T, Nagawa H, Iizuka B, Baba S, Nasu M, Kataoka T, Kashiwagi N, Saniabadi AR. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher 2001; 16: 1-9
42. Hanai H, Watanabe F, Takeuchi K, Iida T, Yamada M, Iwaoka Y, Saniabadi A, Matsushita I, Sato Y, Tozawa K, Arai H, Furuta T, Sugimoto K, Bjarnason I. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 2003; 1: 28-35
43. Kruis W, Dignass A, Steinhagen-Thiessen E, Morgenstern J, Mossner J, Schreiber S, Vecchi M, Malesci A, Reinshagen M, Lofberg R. Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis. World J Gastroenterol 2005; 11: 7001-7006
44. Suzuki Y, Yoshimura N, Fukuda K, Shirai K, Saito Y, Saniabadi AR. A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis. Dig Dis Sci 2006; 51: 2031-2038
45. Suzuki Y, Yoshimura N, Saniabadi AR, Saito Y. Selective granulocyte and monocyte adsorptive apheresis as a firstline treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci 2004; 49: 565-571
46. Ando T, Watanabe O, Furuta R, Maeda O, Nishio Y, Nishiwaki T, Ina K, Kusugami K, Goto H. Predictors of a response to cyclosporine or leukocyte removal therapy in patients with refractory ulcerative colitis. Dig Endosc 2005; 17: 153-158
47. Descos L, Andre F, Andre C, Gillon J, Landais P, Fermanian J. Assessment of appropriate laboratory measurements to reflect the degree of activity of ulcerative colitis. Digestion 1983; 28: 148-152
48. Powell-Tuck J, Day DW, Buckell NA, Wadsworth J, Lennard-Jones JE. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis. Dig Dis Sci 1982; 27: 533-537
49. Binder V. A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis. Scand J Gastroenterol 1970; 5: 627-632
50. Alemayehu G, Jarnerot G. Colonoscopy during an attack of severe ulcerative colitis is a safe procedure and of great value in clinical decision making. Am J Gastroenterol 1991; 86: 187-190
51. Carbonnel F, Lavergne A, Lemann M, Bitoun A, Valleur P, Hautefeuille P, Galian A, Modigliani R, Rambaud JC. Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci 1994; 39: 1550-1557
52. Carbonnel F, Gargouri D, Lemann M, Beaugerie L, Cattan S, Cosnes J, Gendre JP. Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis. Aliment Pharmacol Ther 2000; 14: 273-279
53. Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1964; 1: 89-92
54. Gomes P, du Boulay C, Smith CL, Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 1986; 27: 92-95
55. Holmquist L, Ahren C, Fallstrom SP. Clinical disease activity and inflammatory activity in the rectum in relation to mucosal inflammation assessed by colonoscopy. A study of children and adolescents with chronic inflammatory bowel disease. Acta Paediatr Scand 1990; 79: 527-534
56. Riley SA, Mani V, Goodman MJ, Herd ME, Dutt S, Turnberg LA. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse. Gut 1988; 29: 669-674
57. Korelitz BI, Sommers SC. Responses to drug therapy in ulcerative colitis. Evaluation by rectal biopsy and histopathological changes. Am J Gastroenterol 1975; 64: 365-370
58. Theodossi A, Spiegelhalter DJ, Jass J, Firth J, Dixon M, Leader M, Levison DA, Lindley R, Filipe I, Price A. Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut 1994; 35: 961-968
59. Levine TS, Tzardi M, Mitchell S, Sowter C, Price AB. Diagnostic difficulty arising from rectal recovery in ulcerative colitis. J Clin Pathol 1996; 49: 319-323
60. Rao SS, Holdsworth CD, Read NW. Symptoms and stool patterns in patients with ulcerative colitis. Gut 1988; 29: 342-345
61. Malts SG. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 1961; 30: 393-407
62. Truelove SC, Richards WC. Biopsy studies in ulcerative colitis. Br Med J 1956; 1: 1315-1318
63. Kleer CG, Appelman HD. Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time. Am J Surg Pathol 1998; 22: 983-989
64. Hurlstone DP, Sanders DS, Lobo AJ, McAlindon ME, Cross SS. Prospective evaluation of high-frequency mini-probe ultrasound colonoscopic imaging in ulcerative colitis: a valid tool for predicting clinical severity. Eur J Gastroenterol Hepatol 2005; 17: 1325-1331
65. Matsumoto T, Kuroki F, Mizuno M, Nakamura S, Iida M. Application of magnifying chromoscopy for the assessment of severity in patients with mild to moderate ulcerative colitis. Gastrointest Endosc 1997; 46: 400-405
66. Fujiya M, Saitoh Y, Nomura M, Maemoto A, Fujiya K, Watari J, Ashida T, Ayabe T, Obara T, Kohgo Y. Minute findings by magnifying colonoscopy are useful for the evaluation of ulcerative colitis. Gastrointest Endosc 2002; 56: 535-542